Marksans Pharma Ltd
NSE :MARKSANS BSE :524404 Sector : PharmaceuticalsBuy, Sell or Hold MARKSANS? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
19 Sep 274.44 (-2.41%) | 18 Sep 281.22 (-5.12%) | 17 Sep 296.39 (0.91%) | 16 Sep 293.71 (5.79%) | 13 Sep 277.64 (3.58%) | 12 Sep 268.05 (-1.87%) | 11 Sep 273.15 (3.63%) | 10 Sep 263.59 (2.02%) | 09 Sep 258.37 (-1.79%) | 06 Sep 263.09 (1.58%) | 05 Sep 259.00 (-0.88%) | 04 Sep 261.30 (7.77%) | 03 Sep 242.47 (1.02%) | 02 Sep 240.01 (0.20%) | 30 Aug 239.52 (2.34%) | 29 Aug 234.04 (-2.50%) | 28 Aug 240.05 (1.99%) | 27 Aug 235.36 (0.30%) | 26 Aug 234.65 (3.49%) | 23 Aug 226.74 (-1.45%) | 22 Aug 230.08 (4.68%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Bullish
Medium Term Investors
Very Bullish
Long Term Investors
Very Bullish
Moving Averages
5 DMA
Bearish
284.59
10 DMA
Bearish
274.89
20 DMA
Bullish
258.1
50 DMA
Bullish
223.24
100 DMA
Bullish
192.78
200 DMA
Bullish
175.2
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Sep 19, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 302.85 | 295.93 | 279.3 | - | - |
R2 | 295.93 | 289.18 | 277.68 | 294.97 | - |
R1 | 285.19 | 285.02 | 276.06 | 283.27 | 290.56 |
P | 278.27 | 278.27 | 278.27 | 277.31 | 280.95 |
S1 | 267.53 | 271.52 | 272.82 | 265.61 | 272.9 |
S2 | 260.61 | 267.36 | 271.2 | 259.65 | - |
S3 | 249.87 | 260.61 | 269.58 | - | - |
Key Metrics
EPS
2.68
P/E
102.33
P/B
10.16
Dividend Yield
0.22%
Market Cap
12,437 Cr.
Face Value
1
Book Value
26.98
ROE
16.53%
EBITDA Growth
142.39 Cr.
Debt/Equity
0.1
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Marksans Pharma Ltd Quaterly Results
Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | |
INCOME | 510.13 | 550.23 | 590.93 | 576.54 | 605.57 |
PROFIT | 68.66 | 83.52 | 83.24 | 78.29 | 88.75 |
EPS | 1.52 | 1.84 | 1.84 | 1.73 | 1.96 |
Marksans Pharma Ltd Quaterly Results
Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | |
INCOME | 214.66 | 220.6 | 242.69 | 237.39 | 262.68 |
PROFIT | 44.19 | 31.29 | 25.29 | 32.99 | 32.02 |
EPS | 0.98 | 0.69 | 0.56 | 0.73 | 0.71 |
Profit & Loss (Figures in Rs. Crores)
Marksans Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 801.33 | 897.36 | 822.12 | 900.61 | 1024.59 | 1081.59 | 1519.15 | 1519.79 | 1917.84 | 2301.69 | |
PROFIT | 109.46 | 78.5 | 8.83 | 32.98 | 76.46 | 120.73 | 235.92 | 184.57 | 266.52 | 313.59 | |
EPS | 2.71 | 1.99 | 0 | 0.87 | 1.97 | 2.95 | 5.83 | 4.56 | 5.85 | 6.95 |
Marksans Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 407.32 | 362.66 | 222.12 | 305.81 | 434.8 | 439.22 | 630.16 | 696.65 | 725.87 | 922.59 | |
PROFIT | 67.11 | 71.48 | 11.53 | 12.43 | 43.65 | 37.87 | 98.35 | 103.99 | 102.92 | 133.69 | |
EPS | 1.61 | 1.72 | 0.19 | 0.3 | 1.07 | 0.93 | 2.4 | 2.54 | 2.27 | 2.95 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 45.32 | 45.32 | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 | 53.43 | 53.43 |
Reserves Total | 2,019.74 | 1,699.85 | 1,068.24 | 845.56 | 595.08 | 501.55 | 429.93 | 392.5 | 400.89 | 326.33 |
Equity Share Warrants | 0 | 0 | 93.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 2,065.06 | 1,745.17 | 1,202.27 | 886.49 | 636.01 | 542.48 | 470.86 | 433.43 | 454.32 | 379.76 |
Minority Interest | 20.85 | 19.91 | 20.7 | 18.86 | 13.11 | 10.22 | 9.55 | 6.25 | 8.36 | 8.1 |
Secured Loans | 29.09 | 41.59 | 41.29 | 18.74 | 18.89 | 100.22 | 117.96 | 109.71 | 87.9 | 88.59 |
Unsecured Loans | 214.97 | 81.36 | 69.49 | 15.36 | 10.76 | 0 | 0 | 0 | 0 | 0 |
Total Debt | 244.06 | 122.95 | 110.78 | 34.1 | 29.65 | 100.22 | 117.96 | 109.71 | 87.9 | 88.59 |
Other Liabilities | 4.56 | 3.25 | 1.86 | 7.11 | 6.47 | 11.36 | 11.08 | 11.96 | 0 | 0 |
Total Liabilities | 2,334.53 | 1,891.28 | 1,335.61 | 946.56 | 685.24 | 664.28 | 609.45 | 561.35 | 550.58 | 476.45 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 1,193.49 | 828.26 | 726.27 | 551.93 | 563.24 | 506.26 | 495.35 | 456.49 | 429.47 | 297.78 |
Less: Accumulated Depreciation | 417.55 | 341.95 | 297.96 | 242.56 | 260.52 | 236.54 | 215.97 | 189.52 | 159.82 | 131.89 |
Net Block | 775.94 | 486.31 | 428.31 | 309.37 | 302.72 | 269.72 | 279.38 | 266.97 | 269.65 | 165.89 |
Capital Work in Progress | 9.42 | 9.87 | 2.57 | 11.68 | 0 | 0 | 0 | 0.36 | 0 | 0 |
Investments | 26.99 | 0.54 | 0.44 | 0.26 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 617.94 | 484.74 | 424.44 | 404.32 | 241.84 | 293.25 | 218.12 | 190.09 | 167.79 | 130.11 |
Sundry Debtors | 453.18 | 416.85 | 394.78 | 271.95 | 243.35 | 176.6 | 176.91 | 247.58 | 217.29 | 183.45 |
Cash and Bank Balance | 673.58 | 714.96 | 349.27 | 212.18 | 93.73 | 33.54 | 39.88 | 25.16 | 35.3 | 185.27 |
Loans and Advances | 90.8 | 58.22 | 32.28 | 14.11 | 14.66 | 28.06 | 15.63 | 21.06 | 19.76 | 10 |
Total Current Assets | 1,835.5 | 1,674.77 | 1,200.77 | 902.56 | 593.59 | 531.44 | 450.54 | 483.89 | 440.15 | 508.83 |
Current Liabilities | 313.94 | 257.13 | 268.82 | 242.32 | 165.9 | 126.66 | 87.35 | 162.5 | 119.66 | 140.5 |
Provisions | 21.86 | 26.6 | 18.05 | 31.88 | 40.72 | 5.74 | 29.36 | 23.85 | 51.88 | 57.15 |
Total Current Liabilities & Provisions | 335.81 | 283.73 | 286.87 | 274.19 | 206.62 | 132.41 | 116.72 | 186.35 | 171.54 | 197.65 |
Net Current Assets | 1,499.69 | 1,391.03 | 913.9 | 628.36 | 386.96 | 399.03 | 333.82 | 297.54 | 268.61 | 311.18 |
Deferred Tax Assets | 18.77 | 11.82 | 9.16 | 2.09 | 3.2 | 2.78 | 3.01 | 2.64 | 4.76 | 1.52 |
Deferred Tax Liability | 29.39 | 27.21 | 22.93 | 9.35 | 13.36 | 8.56 | 7.57 | 6.75 | 2.85 | 2.97 |
Net Deferred Tax | -10.62 | -15.39 | -13.77 | -7.26 | -10.16 | -5.78 | -4.56 | -4.11 | 1.91 | -1.45 |
Other Assets | 33.11 | 18.91 | 4.16 | 4.16 | 5.73 | 1.29 | 0.82 | 0.59 | 10.41 | 0.83 |
Total Assets | 2,334.52 | 1,891.27 | 1,335.61 | 946.56 | 685.25 | 664.27 | 609.46 | 561.36 | 550.58 | 476.46 |
Contingent Liabilities | 0 | 1.45 | 1.45 | 19.78 | 48.17 | 30.4 | 10.47 | 0 | 0 | 0 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 45.32 | 45.32 | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 | 40.93 | 53.43 | 53.43 |
Reserves Total | 1,177.39 | 1,066.01 | 650.64 | 558.79 | 464.69 | 429.64 | 388.04 | 377.95 | 369.27 | 304.75 |
Equity Share Warrants | 0 | 0 | 93.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 1,222.71 | 1,111.33 | 784.67 | 599.72 | 505.62 | 470.57 | 428.97 | 418.88 | 422.7 | 358.18 |
Secured Loans | 0 | 0 | 0 | 0 | 0.05 | 77.63 | 66.86 | 73.23 | 40.62 | 49.93 |
Unsecured Loans | 8.13 | 7.69 | 14.31 | 14.37 | 10.76 | 0 | 0 | 0 | 0 | 0 |
Total Debt | 8.13 | 7.69 | 14.31 | 14.37 | 10.81 | 77.63 | 66.86 | 73.23 | 40.62 | 49.93 |
Other Liabilities | 4.47 | 3.18 | 1.86 | 7.11 | 6.47 | 11.36 | 11.08 | 11.96 | 0 | 0 |
Total Liabilities | 1,235.31 | 1,122.2 | 800.84 | 621.2 | 522.9 | 559.56 | 506.91 | 504.07 | 463.32 | 408.11 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 472.78 | 318.89 | 301.34 | 277.25 | 246.62 | 224.9 | 201.83 | 195.61 | 184.48 | 162.47 |
Less : Accumulated Depreciation | 201.2 | 174.95 | 165.83 | 148.17 | 131.44 | 122.28 | 113.94 | 101.69 | 87.01 | 72.45 |
Net Block | 271.58 | 143.94 | 135.51 | 129.08 | 115.18 | 102.62 | 87.89 | 93.92 | 97.47 | 90.02 |
Capital Work in Progress | 0 | 3.91 | 0 | 0 | 0 | 0 | 0 | 0.36 | 0 | 0 |
Investments | 292.75 | 266.29 | 236.51 | 236.34 | 236.07 | 236.07 | 236.07 | 234.29 | 231.44 | 67.62 |
Inventories | 190.85 | 130.95 | 103.68 | 93.69 | 74.6 | 70.36 | 42.29 | 29.24 | 43.74 | 51.03 |
Sundry Debtors | 370.17 | 305.49 | 246.78 | 168.93 | 161.87 | 177.83 | 168.87 | 154.8 | 133.41 | 124.63 |
Cash and Bank Balance | 312.23 | 440.26 | 224.05 | 105.61 | 3.35 | 1.8 | 0.71 | 2.56 | 3.13 | 167.54 |
Loans and Advances | 47.46 | 36.52 | 14.92 | 2.89 | 4.23 | 22.01 | 20.63 | 30.01 | 23.76 | 25.46 |
Total Current Assets | 920.71 | 913.22 | 589.43 | 371.12 | 244.05 | 272.01 | 232.51 | 216.61 | 204.04 | 368.66 |
Current Liabilities | 264.45 | 206.71 | 147.64 | 100.82 | 64.29 | 44.25 | 41.92 | 21.31 | 32.08 | 78.06 |
Provisions | 6.88 | 7.32 | 8.12 | 10.18 | 1.79 | 1.14 | 2.45 | 15.04 | 38.49 | 40.45 |
Total Current Liabilities & Provisions | 271.33 | 214.03 | 155.76 | 111 | 66.08 | 45.39 | 44.37 | 36.36 | 70.57 | 118.51 |
Net Current Assets | 649.38 | 699.19 | 433.66 | 260.11 | 177.98 | 226.62 | 188.14 | 180.25 | 133.47 | 250.15 |
Deferred Tax Assets | 2 | 1.87 | 0.89 | 0.43 | 0.84 | 0.61 | 0.61 | 0.58 | 1.52 | 1.52 |
Deferred Tax Liability | 11.41 | 10.51 | 9.9 | 8.92 | 11.64 | 7.64 | 6.62 | 5.92 | 1.83 | 2.02 |
Net Deferred Tax | -9.41 | -8.64 | -9.01 | -8.49 | -10.8 | -7.03 | -6.01 | -5.34 | -0.31 | -0.5 |
Other Assets | 31.01 | 17.5 | 4.16 | 4.16 | 4.47 | 1.29 | 0.82 | 0.59 | 1.25 | 0.83 |
Total Assets | 1,235.31 | 1,122.19 | 800.83 | 621.21 | 522.9 | 559.56 | 506.91 | 504.07 | 463.32 | 408.11 |
Contingent Liabilities | 0 | 1.45 | 1.45 | 115.1 | 140.38 | 71.35 | 11.05 | 0 | 9.71 | 0 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 423.53 |
Depreciation | 74.27 |
Interest (Net) | -22.58 |
P/L on Sales of Assets | -0.09 |
P/L on Sales of Invest | -0.05 |
Prov. and W/O (Net) | 5.16 |
P/L in Forex | 3.04 |
Total Adjustments (PBT and Ext... | 55.42 |
Operating Profit before Workin... | 478.95 |
Trade and 0ther Receivables | -37.17 |
Inventories | -112.67 |
Total Adjustments (OP before W... | -126.19 |
Cash Generated from/(used in) ... | 352.76 |
Direct Taxes Paid | -122.35 |
Total Adjustments(Cash Generat... | -122.35 |
Cash Flow before Extraordinary... | 230.41 |
Net Cash from Operating Activi... | 230.41 |
Purchased of Fixed Assets | -208.84 |
Sale of Fixed Assets | 0.85 |
Purchase of Investments | -37 |
Sale of Investments | 11.05 |
Interest Received | 30.87 |
Net Cash used in Investing Act... | -140.84 |
Of the Short Term Borrowings | -12.5 |
Of Financial Liabilities | -28.4 |
Dividend Paid | -22.66 |
Interest Paid | -5.17 |
Net Cash used in Financing Act... | -68.73 |
Net Profit before Tax and Extr... | 171.89 |
Depreciation | 29.13 |
Interest (Net) | -21.51 |
Dividend Received | 25.77 |
P/L on Sales of Assets | -0.03 |
P/L on Sales of Invest | -0.05 |
Prov. and W/O (Net) | 3.11 |
P/L in Forex | 3.04 |
Total Adjustments (PBT and Ext... | -16.4 |
Operating Profit before Workin... | 155.5 |
Trade and 0ther Receivables | -70.24 |
Inventories | -59.9 |
Total Adjustments (OP before W... | -82.68 |
Cash Generated from/(used in) ... | 72.82 |
Direct Taxes Paid | -38.76 |
Total Adjustments(Cash Generat... | -38.76 |
Cash Flow before Extraordinary... | 34.05 |
Net Cash from Operating Activi... | 34.05 |
Purchased of Fixed Assets | -155.67 |
Sale of Fixed Assets | 0.33 |
Purchase of Investments | -37 |
Sale of Investments | 11.05 |
Interest Received | 19.65 |
Net Cash used in Investing Act... | -114.22 |
Of Financial Liabilities | -3.56 |
Dividend Paid | -22.66 |
Net Cash used in Financing Act... | -26.22 |
Company Details
Registered Office |
|
Address | 11th Flr GRANDEUR Oshiwara, Veera Desai Extn Rd Andheri(W) |
City | Mumbai |
State | Maharashtra |
Pin Code | 400053 |
Tel. No. | 91-22-40012000 |
Fax. No. | 91-22-40012011 |
companysecretary@marksanspharma.com ; info@marksan | |
Internet | http://www.marksanspharma.com |
Registrars |
|
Address | 11th Flr GRANDEUR Oshiwara |
City | Mumbai |
State | Maharashtra |
Pin Code | 400053 |
Tel. No. | 91-22-40012000 |
Fax. No. | 91-22-40012011 |
companysecretary@marksanspharma.com ; info@marksan | |
Internet | http://www.marksanspharma.com |
Management |
|
Name | Designation |
Mark Saldanha | Chairman & Managing Director |
Harshavardhan Panigrahi | Company Sec. & Compli. Officer |
Seetharama Raju Buddharaju | Non-Exec. & Independent Dir. |
Sandra Saldanha | Whole-time Director |
Digant Mahesh Parikh | Non-Exec. & Independent Dir. |
Varddhman Vikramaditya Jain | Whole-time Director |
Abhinna Sundar Mohanty | Non-Exec. & Independent Dir. |
Sunny Sharma | Non Executive Director |
Shailaja Vardhan | Independent Director |